Preparation of anti-inflammatory mesenchymal stem/precursor cells (MSCs) through sphere formation using hanging-drop culture technique

Current Protocols in Stem Cell Biology

Volumn 1, Issue SUPPL.28, 2014, Pages

  Bartosh, Thomas J ^a   Ylostalo, Joni H ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Activation; Anti inflammatory; LPS; Macrophage; MSC; Sphere; Spheroid

Indexed keywords

COMPLEMENTARY DNA; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PROTEIN; STC 1 PROTEIN; TSG6 PROTEIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

ADULT STEM CELL; ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL CULTURE; CELL STIMULATION; CELL SUSPENSION; CELL TRANSFER; COCULTURE; CULTURE TECHNIQUE; DNA SYNTHESIS; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FILTERS AND MEMBRANES; GENE EXPRESSION; HANGING DROP CULTURE TECHNIQUE; IMMUNITY; INFLAMMATION; MACROPHAGE CULTURE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; ACTIVATION; ANIMAL; ANTI-INFLAMMATORY; CELL ADHESION; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FREEZING; GENE EXPRESSION REGULATION; HUMAN; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MOUSE; MSC; MULTICELLULAR SPHEROID; SECRETION (PROCESS); SPHERE; SPHEROID;

ACTIVATION; ANTI-INFLAMMATORY; LPS; MACROPHAGE; MSC; SPHERE; SPHEROID;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CULTURE TECHNIQUES; DINOPROSTONE; FREEZING; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MICE; SPHEROIDS, CELLULAR;

EID: 84902505700     PISSN: 19417322     EISSN: 19388969     Source Type: Journal    
DOI: 10.1002/9780470151808.sc02b06s28     Document Type: Article

References (26)

1. Achilli, T.M., Meyer, J., and Morgan, J.R. 2012. Advances in the formation, use and understanding of multi-cellular spheroids. Exp. Opin. Biol. Ther. 12:1347-1360.
2. Arufe, M.C., De la Fuente, A., Fuentes-Boquete, I., De Toro, F.J., and Blanco, F.J. 2009. Differentiation of synovial CD-105(+) human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J. Cell Biochem. 108:145-155.
3. Baraniak, P.R. and McDevitt, T.C. 2012. Scaffoldfree culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential. Cell Tissue Res. 347:701-711.
4. Bartosh, T.J., Ylostalo, J.H., Mohammadipoor, A., Bazhanov, N., Coble, K., Claypool, K., Lee, R.H., Choi, H., and Prockop, D.J. 2010. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc. Natl. Acad. Sci. U.S.A. 107:13724-13729.
5. Faulkner-Jones, A., Greenhough, S., King, J.A., Gardner, J., Courtney, A., and Shu, W. 2013. Development of a valve-based cell printer for the formation of human embryonic stem cell spheroid aggregates. Biofabrication 5:015013.
6. Frith, J.E., Thomson, B., and Genever, P.G. 2009. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng. C Methods 16:735-749.
7. Jing, Y. and Jian-Xiong, Y. 2011. 3-D spheroid culture of bone marrow mesenchymal stem cell of rhesus monkey with improved multidifferentiation potential to epithelial progenitors and neuron in vitro. Clin. Experiment. Ophthalmol. 39:808-819.
8. Keating, A. 2012. Mesenchymal stromal cells: New directions. Cell Stem Cell 10:709-716.
9. Martinez, F.O., Helming, L., and Gordon, S. 2009. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 27:451-483.
10. Murray, P.J. and Wynn, T.A. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11:723-737.
11. Nemeth, K., Leelahavanichkul, A., Yuen, P.S., Mayer, B., Parmelee, A., Doi, K., Robey, P.G., Leelahavanichkul, K., Koller, B.H., Brown, J.M., Hu, X., Jelinek, I., Star, R.A., and Mezey, E. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15:42-49.
12. Ortega-Gomez, A., Perretti, M., and Soehnlein, O. 2013. Resolution of inflammation: Anintegrated view. EMBO Mol. Med. 5:661-674.
13. Page, H., Flood, P., and Reynaud, E.G., 2013. Three-dimensional tissue cultures: Current trends and beyond. Cell Tissue Res. 352:123-131.
14. Potapova, I.A., Brink, P.R., Cohen, I.S., and Doronin, S.V. 2008a. Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J. Biol. Chem. 283:13100-13107.
15. Potapova, I.A., Doronin, S.V., Kelly, D.J., Rosen, A.B., Schuldt, A.J., Lu, Z., Kochupura, P.V., Robinson, R.B., Rosen, M.R., Brink, P.R., Gaudette, G.R., and Cohen, I.S. 2008b. Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am. J. Physiol. Heart Circ. Physiol. 295:2257-2263.
16. Prockop, D.J. and Oh, J.Y. 2012. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol. Ther. 20:14-20.
17. Prockop, D.J., Kota, D.J., Bazhanov, N., and Reger, R.L. 2010. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J. Cell Mol. Med. 14:2190-2199.
18. Qihao, Z., Xigu, C., Guanghui, C., and Weiwei, Z. 2007. Spheroid formation and differentiation into hepatocyte-like cells of rat mesenchymal stem cell induced by co-culture with liver cells. DNA Cell Biol. 26:497-503.
19. Ranganath, S.H., Levy, O., Inamdar, M.S., and Karp, J.M. 2012. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10:244-258.
20. Saleh, F.A. and Genever, P.G. 2011. Turning round: Multipotent stromal cells, a three-dimensional revolution? Cytotherapy 13:903-912.
21. Saleh, F.A., Whyte, M., and Genever, P.G. 2011. Effects of endothelial cells on humanmesenchymal stem cell activity in a three-dimensional in vitro model. Eur. Cell Mater. 22:242-257; discussion 257.
22. Suzuki, S., Muneta, T., Tsuji, K., Ichinose, S., Makino, H., Umezawa, A., and Sekiya, I. 2012. Properties and usefulness of aggregates of synovialmesenchymal stem cells as a source for cartilage regeneration. Arthritis Res. Ther. 14:136.
23. Wang, C.C., Chen, C.H., Hwang, S.M., Lin, W.W., Huang, C.H., Lee, W.Y., Chang, Y., and Sung, H.W. 2009a. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells 27:724-732.
24. Wang, W., Itaka, K., Ohba, S., Nishiyama, N., Chung, U.I., Yamasaki, Y., and Kataoka, K. 2009b. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotentmesenchymal stem cells. Biomaterials 30:2705-2715.
25. Xie, Q.P., Huang, H., Xu, B., Dong, X., Gao, S.L., Zhang, B., andWu,Y.L. 2009. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation 77:483-491.
26. Ylostalo, J.H., Bartosh, T.J., Coble, K., and Prockop, D.J. 2012. Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an antiinflammatory phenotype. Stem Cells 30:2283-2296.